Residents are bracing for the worst, wondering whether measures taken so far are enough to keep devastation of the Queens community at bay.
NYS Entity Status
NYS Filing Date
JUNE 17, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2014 - EASTERN LONG ISLAND ST PAUL COMMUNITY DEVELOPMENT CORP.
AROUND THE WEB
- Could the Rockaways Survive Another Sandy?
By LUIS FERRÉ-SADURNÍ - Thursday Jul 13, 2017
- The Gang Murders in the Suburbs
By LIZ ROBBINS and NADIA T. RODRIGUEZ - Wednesday Jul 12, 2017
Four young Latino men went to hang out in the woods on Long Island one night during spring break. They ended up victims of the brutal gang MS-13.
- The Mayor and the Restaurateur: How de Blasio Sought Help for an Early Donor
By WILLIAM NEUMAN and WILLIAM K. RASHBAUM - Monday Jul 24, 2017
Federal investigators, while declining to prosecute, still questioned City Hall’s conduct. Was the administration doing favors for contributors?
- How to Get to New York During Penn Station’s Summer Repairs
By TOM WRIGHT-PIERSANTI - Thursday Jul 6, 2017
Starting July 10, repairs at Penn Station will disrupt the daily commute for thousands of Long Island Rail Road and New Jersey Transit riders. Here is a guide to help navigate the rails this summer.
- FDA advisers review data on potential 1st US gene therapy
By LINDA A. JOHNSON, AP Medical Writer - Wednesday Jul 12, 2017
Cancer experts who advise government regulators are reviewing what could be the first gene therapy approved in the U.S.The Food and Drug Administration panel is holding a hearing Wednesday to discuss the treatment developed by the University of Pennsylvania and Novartis Corp. The drugmaker is seeking approval to use the one-time treatment for children and young adults with advanced leukemia.
- Novel leukemia treatment could be 1st US gene therapy
By Associated Press - Thursday Jul 13, 2017
A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of Pennsylvania and Novartis Corp. The FDA usually follows recommendations from its expert panels, but isn’t...